NMTR

Q: What is the price of 9 Meters Biopharma (NMTR) today?

The current price of 9 Meters Biopharma (NMTR) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does 9 Meters Biopharma (NMTR) pay dividends?

9 Meters Biopharma (NMTR) did not pay dividends over the past year.

9 Meters Biopharma Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

0.06

p/bv

0.60

DIVIDEND YIELD

-357.02%

NMTR price

NMTR

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment NMTR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NMTR

review the fundamentals of 9 Meters Biopharma shares

P/E

0.06

Sector: -4.11 Industry: -4.11

P/S (PSR)

Sector: -3.78 Industry: -3.78

P/BV

0.60

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

-357.02%

Sector: - Industry: -

ROA

-738.37%

Sector: -61.23% Industry: -61.23%

ROE

1,091.65%

Sector: -60.44% Industry: -60.44%

ROIC

Sector: -1,165.26% Industry: -1,165.26%

NET MARGIN

0.00%

Sector: -39.16% Industry: -39.16%

GROSS MARGIN

0.00%

Sector: 37.92% Industry: 37.92%

OPERATING MARGIN

0.00%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

0.06

Sector: -4.00 Industry: -4.00

EV/EBIT

0.06

Sector: -4.22 Industry: -4.22

PRICE-TO-ASSETS

-0.41

Sector: 1.44 Industry: 1.44

BVPS

-0.46

Sector: 1.88 Industry: 1.88

EPS

-5.06

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

-0.68

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

-0.68

Sector: 0.38 Industry: 0.38

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

13.33%

Sector: - Industry: -

Fundamentals NMTR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	20.93	7.08	33.81%	2.23%	$ 560.91 B	28.46%
PFE	20.17	1.68	8.35%	6.24%	$ 156.71 B	12.42%
ABBV	87.13	0.00	0.00%	3.19%	$ 368.21 B	6.91%
NVO	11.49	5.92	51.50%	4.60%	$ 179.95 B	33.05%
MRK	16.19	0.00	0.00%	2.79%	$ 295.53 B	28.08%
AZN	31.07	6.52	20.99%	1.56%	$ 317.64 B	17.41%
GILD	20.09	7.56	37.62%	2.32%	$ 170.95 B	28.90%
BMY	17.19	-3.56	-20.72%	4.18%	$ 121.26 B	14.64%
ZTS	20.05	16.09	80.25%	1.66%	$ 53.60 B	28.23%
REGN	17.16	2.47	14.41%	0.48%	$ 77.31 B	31.41%
HALO	25.80	167.51	649.21%	0.00%	$ 8.18 B	22.69%
AMGN	24.84	22.12	89.06%	2.72%	$ 191.51 B	20.98%
MCK	24.55	-1,076.41	-4,383.84%	0.37%	$ 106.56 B	1.09%
VRTX	28.35	6.00	21.18%	0.00%	$ 112.06 B	32.94%
CAH	30.39	-18.70	-61.56%	0.95%	$ 50.50 B	0.68%
HRMY	10.77	1.96	18.24%	0.00%	$ 1.71 B	18.27%
ADMA	17.83	5.49	30.78%	0.00%	$ 2.62 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NMTR Historical Dividends

current DY: -357.02%

5-year average DY: -213.86%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	06/28/2024	07/29/2024	0,20000000
Dividends	03/25/2024	04/25/2024	0,20000000
Dividends	12/26/2023	01/26/2024	0,20000000
Dividends	09/21/2023	10/26/2023	0,30000000
Dividends	06/16/2023	07/26/2023	0,30000000
Dividends	03/20/2023	04/26/2023	0,40000000
Dividends	12/27/2022	01/26/2023	0,25440000
Dividends	09/26/2022	10/26/2022	0,01280000
Dividends	06/27/2022	07/25/2022	0,25600000
Dividends	03/24/2022	04/25/2022	0,25600000
Dividends	12/27/2021	01/25/2022	0,27200000
Dividends	09/23/2021	10/25/2021	0,27200000
Dividends	06/24/2021	07/26/2021	0,27200000
Dividends	03/25/2021	04/26/2021	0,27200000
Dividends	12/17/2020	01/25/2021	0,08000000
Dividends	09/24/2020	10/26/2020	0,06400000
Dividends	07/01/2020	07/27/2020	0,04000000
Dividends	12/20/2019	01/27/2020	0,80000000
Dividends	09/19/2019	10/25/2019	0,80000000
Dividends	06/24/2019	07/25/2019	0,80000000
Dividends	03/29/2019	04/25/2019	0,80000000
Dividends	12/14/2018	01/25/2019	0,80000000
Dividends	09/27/2018	10/26/2018	0,80000000
Dividends	06/28/2018	07/26/2018	0,80000000
Dividends	03/29/2018	04/26/2018	0,80000000
Dividends	12/18/2017	01/25/2018	0,80000000
Dividends	09/25/2017	10/25/2017	0,80000000
Dividends	06/26/2017	07/25/2017	0,80000000
Dividends	03/27/2017	04/25/2017	0,80000000
Dividends	12/27/2016	01/26/2017	0,96000000
Dividends	09/26/2016	10/28/2016	0,96000000

ABOUT 9 Meters Biopharma

9 Meters Biopharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

16 years

Founded: 2010

2016

Time since IPO - 10 years

12

Employees

9 Meters Biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-3.81 Millions, with shareholders equity totaling $-6.30 Millions.

The company employs approximately 12 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, 9 Meters Biopharma Inc. reported $- in revenue, generating net income of $-68.76 Millions.

Key financial metrics include a P/E ratio of 0.06, a price-to-book (P/B) ratio of 0.60, and a trailing twelve-month dividend yield of -357.02%.

The company trades under the ticker NMTR.

Market cap

$ -3.81 Millions

Net worth

$ -6.30 Millions

$ -6,299,205.00

Assets

$ 9.31 Millions

$ 9,313,037.00

Total Shares Outstanding

13.59 Millions

13,591,000

Average Daily Trading Volume

$ 66.60 Thousand

$ 66,598.00

Sector

Health Care

Industry

Biotechnology

NMTR

NMTR revenue and profits

Financial Results NMTR

DRAG THE FRAME TO SEE MORE DATA

NMTR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 859.04 26,37% (12M)

P/E

24.55

0.37%

ROE

-4,383.84%

P/BV

-1,076.41

CAH - Cardinal Health

$ 211.18 62,81% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.70

JNJ - Johnson & Johnson

$ 230.69 51,98% (12M)

P/E

20.93

2.23%

ROE

33.81%

P/BV

7.08

PFE - Pfizer

$ 27.52 33,93% (12M)

P/E

20.17

6.24%

ROE

8.35%

P/BV

1.68

ABBV - AbbVie

$ 203.71 24,66% (12M)

P/E

87.13

3.19%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 117.10 55,88% (12M)

P/E

16.19

2.79%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 200.69 50,49% (12M)

P/E

31.07

1.56%

ROE

20.99%

P/BV

6.52

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 859.04 26,37% (12 M)

P/L

24.55

0.37%

ROE

-4,383.84%

P/VP

-1,076.41

CAH - Cardinal Health

$ 211.18 62,81% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.70

JNJ - Johnson & Johnson

$ 230.69 51,98% (12 M)

P/L

20.93

2.23%

ROE

33.81%

P/VP

7.08

PFE - Pfizer

$ 27.52 33,93% (12 M)

P/L

20.17

6.24%

ROE

8.35%

P/VP

1.68

ABBV - AbbVie

$ 203.71 24,66% (12 M)

P/L

87.13

3.19%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 117.10 55,88% (12 M)

P/L

16.19

2.79%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 200.69 50,49% (12 M)

P/L

31.07

1.56%

ROE

20.99%

P/VP

6.52

Frequently Asked Questions

What is the price of 9 Meters Biopharma (NMTR) today?

The current price of 9 Meters Biopharma (NMTR) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does 9 Meters Biopharma (NMTR) pay dividends?

9 Meters Biopharma (NMTR) did not pay dividends over the past year.

Is 9 Meters Biopharma (NMTR) a good investment?

9 Meters Biopharma (NMTR) is currently trading at $ 0.00 with a P/E ratio of 0.06%. This represents a -477% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of -357.02%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy 9 Meters Biopharma (NMTR) stock?

You can buy 9 Meters Biopharma (NMTR) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NMTR and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of 9 Meters Biopharma (NMTR) yield today?

Over the past month, 9 Meters Biopharma (NMTR) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of -357.02%.

If you were to purchase 100 shares of 9 Meters Biopharma (NMTR) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NMTR

9 Meters Biopharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NMTR

review the fundamentals of 9 Meters Biopharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: -357.02%

5-year average DY: -213.86%

type

Ex - Dividend Date

payment date

value

ABOUT 9 Meters Biopharma

9 Meters Biopharma Inc.

United States

16 years

2016

12

PROFIT X PRICE NMTR

Financial Results NMTR

NMTR cash flow

Asset, Revenue and Profit Growth - NMTR

NMTR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions